1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept
Compounds of the formula I: and pharmaceutically acceptable salts thereof wherein X is N, Y is S, Z is -(CRaRb)r-, A is -NR3, m is 2, n is 1, q is 2, R2 is optioinally substituted aryl or optionally substituted heteroaryl, and p, R1, R3, R4, R5, R6, R7, R8, R9, and R10, are as defined herein. The in...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
07.02.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compounds of the formula I: and pharmaceutically acceptable salts thereof wherein X is N, Y is S, Z is -(CRaRb)r-, A is -NR3, m is 2, n is 1, q is 2, R2 is optioinally substituted aryl or optionally substituted heteroaryl, and p, R1, R3, R4, R5, R6, R7, R8, R9, and R10, are as defined herein. The invention also provides methods for preparing, compositions comprising, and methods for using compounds of formula I for treatment of central nervous system diseases. |
---|---|
Bibliography: | Application Number: CN200580002612 |